| scholarly article | Q13442814 |
| P50 | author | Steven J Frank | Q61160397 |
| Baris Turkbey | Q88769455 | ||
| Drew Moghanaki | Q114060698 | ||
| P2093 | author name string | Behfar Ehdaie | |
| Neha Vapiwala | |||
| Mukesh Harisinghani | |||
| Patrick W McLaughlin | |||
| P2860 | cites work | PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2 | Q29037908 |
| Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. | Q30664726 | ||
| Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference | Q30995961 | ||
| A study of prostate delineation referenced against a gold standard created from the visible human data | Q31126638 | ||
| Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology | Q33590993 | ||
| Radiographic and anatomic basis for prostate contouring errors and methods to improve prostate contouring accuracy | Q46116129 | ||
| Geographical distribution of lymph node metastases on MR lymphography in prostate cancer patients | Q46690347 | ||
| Quantifying the impact of seminal vesicle invasion identified using endorectal magnetic resonance imaging on PSA outcome after radiation therapy for patients with clinically localized prostate cancer | Q47600877 | ||
| Length of capsular contact for diagnosing extraprostatic extension on prostate MRI: Assessment at an optimal threshold. | Q50850680 | ||
| Transperineal magnetic resonance image targeted prostate biopsy versus transperineal template prostate biopsy in the detection of clinically significant prostate cancer. | Q50904451 | ||
| A survey of current clinical practice in permanent and temporary prostate brachytherapy: 2010 update. | Q50965730 | ||
| Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging? | Q52905767 | ||
| Clinical impact of 18F-choline PET/CT in patients with recurrent prostate cancer. | Q53171288 | ||
| Prostate contouring variation: can it be fixed? | Q53229259 | ||
| Is supplemental external beam radiation therapy necessary for patients with higher risk prostate cancer treated with 103Pd? Results of two prospective randomized trials. | Q53476177 | ||
| The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT. | Q53553364 | ||
| Is supplemental external beam radiation therapy essential to maximize brachytherapy outcomes in patients with unfavorable intermediate-risk disease? | Q53811017 | ||
| Clinically Significant Prostate Cancer Local Recurrence After Radiation Therapy Occurs at the Site of Primary Tumor: Magnetic Resonance Imaging and Step-Section Pathology Evidence | Q57392756 | ||
| Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP) | Q57944300 | ||
| Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy Findings | Q63966248 | ||
| Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET | Q68101517 | ||
| Detection of bony metastases of androgen-independent prostate cancer by PET-FDG | Q71827091 | ||
| Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET | Q73081517 | ||
| Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography | Q73181679 | ||
| Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET | Q74046695 | ||
| Prostate cancer sampled on sextant needle biopsy: significance of cancer on multiple cores from different areas of the prostate | Q78115198 | ||
| MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results | Q80534791 | ||
| A phase II study of external beam radiotherapy combined with permanent source brachytherapy for intermediate-risk, clinically localized adenocarcinoma of the prostate: preliminary results of RTOG P-0019 | Q81484525 | ||
| Magnetic Resonance Lymphography–Guided Selective High-Dose Lymph Node Irradiation in Prostate Cancer | Q82448314 | ||
| American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy | Q83296528 | ||
| Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate | Q83437107 | ||
| High occurrence of aberrant lymph node spread on magnetic resonance lymphography in prostate cancer patients with a biochemical recurrence after radical prostatectomy | Q84272335 | ||
| Diffusion tensor magnetic resonance tractography of the prostate: feasibility for mapping periprostatic fibers | Q84502245 | ||
| Suggestion for the prostatic fossa clinical target volume in adjuvant or salvage radiotherapy after a radical prostatectomy | Q95522506 | ||
| Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: implications for prostate brachytherapy | Q34153708 | ||
| Noninvasive detection of clinically occult lymph-node metastases in prostate cancer | Q34207093 | ||
| Nuclear medicine techniques for the diagnosis and therapy of prostate carcinoma | Q34422071 | ||
| Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? | Q34534796 | ||
| Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy | Q34614216 | ||
| Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis | Q34681143 | ||
| Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy | Q34794205 | ||
| The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer | Q35043569 | ||
| Physician variation in management of low-risk prostate cancer: a population-based cohort study | Q35213290 | ||
| Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging | Q35354750 | ||
| Diagnosis of Occult Bone Metastases: Positron Emission Tomography | Q35576791 | ||
| Inter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone Disease | Q36001776 | ||
| Sensitivity, Specificity, and Predictors of Positive 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis | Q36065223 | ||
| Radical prostatectomy versus observation for localized prostate cancer | Q36194308 | ||
| Current status of lymph node-positive prostate cancer: Incidence and predictors of outcome | Q36516545 | ||
| Tumor focality in prostate cancer: implications for focal therapy | Q37813395 | ||
| Understanding the pathological features of focality, grade and tumour volume of early-stage prostate cancer as a foundation for parenchyma-sparing prostate cancer therapies: active surveillance and focal targeted therapy | Q37864722 | ||
| Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls | Q38028905 | ||
| Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO Guideline | Q38109403 | ||
| Application of C-11-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature | Q38128388 | ||
| One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): toward an upfront simplified "all-in-one" imaging approach? | Q38174546 | ||
| Can MRI replace serial biopsies in men on active surveillance for prostate cancer? | Q38194869 | ||
| Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature | Q38346015 | ||
| Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine | Q38479113 | ||
| A practical primer on PI-RADS version 2: a pictorial essay. | Q38777739 | ||
| Vessel-sparing radiation and functional anatomy-based preservation for erectile function after prostate radiotherapy. | Q38865004 | ||
| Kinetic analyses of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid transport in Xenopus laevis oocytes expressing human ASCT2 and SNAT2. | Q39155744 | ||
| Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. | Q39278530 | ||
| Can Confirmatory Biopsy be Omitted in Patients with Prostate Cancer Favorable Diagnostic Features on Active Surveillance? | Q40467014 | ||
| In-parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance | Q40561072 | ||
| Pattern of Progression after Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Nodal Recurrences | Q40773776 | ||
| The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance. | Q40884788 | ||
| Dose escalation to dominant intraprostatic lesions with MRI-transrectal ultrasound fusion High-Dose-Rate prostate brachytherapy. Prospective phase II trial. | Q40896520 | ||
| Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI study | Q41483390 | ||
| Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer | Q41686096 | ||
| Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost | Q42199666 | ||
| Salvage radiation in men after prostate-specific antigen failure and the risk of death | Q43625657 | ||
| Commentary on "Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy". | Q44293266 | ||
| Management of Postprostatectomy Biochemical Relapse With Salvage Radiotherapy: Results of an International Survey | Q44992366 | ||
| Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results | Q46050638 | ||
| P433 | issue | 1 | |
| P921 | main subject | computed tomography | Q32566 |
| adaptive radiation therapy | Q180507 | ||
| prostate cancer | Q181257 | ||
| P304 | page(s) | 21-33 | |
| P577 | publication date | 2016-08-31 | |
| P1433 | published in | Seminars in Radiation Oncology | Q14330413 |
| P1476 | title | Advances in Prostate Cancer Magnetic Resonance Imaging and Positron Emission Tomography-Computed Tomography for Staging and Radiotherapy Treatment Planning | |
| P478 | volume | 27 |
| Q92073904 | Detection of Dominant Intra-prostatic Lesions in Patients With Prostate Cancer Using an Artificial Neural Network and MR Multi-modal Radiomics Analysis |
| Q41689116 | Focal therapy for prostate cancer: the technical challenges. |
| Q94483998 | Harnessing the potential of multimodal radiotherapy in prostate cancer |
| Q38636446 | Magnetic resonance imaging for prostate cancer before radical and salvage radiotherapy: What radiation oncologists need to know |
| Q30354652 | Nanoparticles as Theranostic Vehicles in Experimental and Clinical Applications-Focus on Prostate and Breast Cancer. |
| Q39356209 | Radical Prostatectomy for High-risk Localized or Node-Positive Prostate Cancer: Removing the Primary. |
| Q96305377 | Segmentation of the Prostatic Gland and the Intraprostatic Lesions on Multiparametic Magnetic Resonance Imaging Using Mask Region-Based Convolutional Neural Networks |
| Q64324920 | Stereotactic Body Radiotherapy for Primary Prostate Cancer |
Search more.